- NBIX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $48.7 million.
- NBIX has traded 51,780 shares today.
- NBIX is down 3.5% today.
- NBIX was up 5.7% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in NBIX with the Ticky from Trade-Ideas. See the FREE profile for NBIX NOW at Trade-Ideas More details on NBIX: Neurocrine Biosciences, Inc. discovers and develops pharmaceuticals for the treatment of neurological and endocrine-related diseases and disorders in the United States. Currently there are 8 analysts that rate Neurocrine Biosciences a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Neurocrine Biosciences has been 1.1 million shares per day over the past 30 days. Neurocrine has a market cap of $3.4 billion and is part of the health care sector and drugs industry. The stock has a beta of -0.91 and a short float of 9.4% with 4.83 days to cover. Shares are up 79.2% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.